Jocelyn M Biagini Myers1, Eric Schauberger2, Hua He3, Lisa J Martin4, John Kroner5, Gregory M Hill5, Patrick H Ryan6, Grace K LeMasters7, David I Bernstein8, James E Lockey7, S Hasan Arshad9, Ramesh Kurukulaaratchy9, Gurjit K Khurana Hershey10. 1. Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio. 2. Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 3. Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 4. Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio. 5. Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 6. Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio. 7. Department of Environmental Health, University of Cincinnati, Cincinnati, Ohio. 8. Department of Environmental Health, University of Cincinnati, Cincinnati, Ohio; Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio. 9. David Hide Asthma & Allergy Research Centre, St Mary's Hospital, Newport, Isle of Wight, United Kingdom. 10. Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio. Electronic address: Gurjit.Hershey@cchmc.org.
Abstract
BACKGROUND: Asthma phenotypes are currently not amenable to primary prevention or early intervention because their natural history cannot be reliably predicted. Clinicians remain reliant on poorly predictive asthma outcome tools because of a lack of better alternatives. OBJECTIVE: We sought to develop a quantitative personalized tool to predict asthma development in young children. METHODS: Data from the Cincinnati Childhood Allergy and Air Pollution Study (n = 762) birth cohort were used to identify factors that predicted asthma development. The Pediatric Asthma Risk Score (PARS) was constructed by integrating demographic and clinical data. The sensitivity and specificity of PARS were compared with those of the Asthma Predictive Index (API) and replicated in the Isle of Wight birth cohort. RESULTS: PARS reliably predicted asthma development in the Cincinnati Childhood Allergy and Air Pollution Study (sensitivity = 0.68, specificity = 0.77). Although both the PARS and API predicted asthma in high-risk children, the PARS had improved ability to predict asthma in children with mild-to-moderate asthma risk. In addition to parental asthma, eczema, and wheezing apart from colds, variables that predicted asthma in the PARS included early wheezing (odds ratio [OR], 2.88; 95% CI, 1.52-5.37), sensitization to 2 or more food allergens and/or aeroallergens (OR, 2.44; 95% CI, 1.49-4.05), and African American race (OR, 2.04; 95% CI, 1.19-3.47). The PARS was replicated in the Isle of Wight birth cohort (sensitivity = 0.67, specificity = 0.79), demonstrating that it is a robust, valid, and generalizable asthma predictive tool. CONCLUSIONS: The PARS performed better than the API in children with mild-to-moderate asthma. This is significant because these children are the most common and most difficult to predict and might be the most amenable to prevention strategies.
BACKGROUND:Asthma phenotypes are currently not amenable to primary prevention or early intervention because their natural history cannot be reliably predicted. Clinicians remain reliant on poorly predictive asthma outcome tools because of a lack of better alternatives. OBJECTIVE: We sought to develop a quantitative personalized tool to predict asthma development in young children. METHODS: Data from the Cincinnati Childhood Allergy and Air Pollution Study (n = 762) birth cohort were used to identify factors that predicted asthma development. The Pediatric Asthma Risk Score (PARS) was constructed by integrating demographic and clinical data. The sensitivity and specificity of PARS were compared with those of the Asthma Predictive Index (API) and replicated in the Isle of Wight birth cohort. RESULTS: PARS reliably predicted asthma development in the Cincinnati Childhood Allergy and Air Pollution Study (sensitivity = 0.68, specificity = 0.77). Although both the PARS and API predicted asthma in high-risk children, the PARS had improved ability to predict asthma in children with mild-to-moderate asthma risk. In addition to parental asthma, eczema, and wheezing apart from colds, variables that predicted asthma in the PARS included early wheezing (odds ratio [OR], 2.88; 95% CI, 1.52-5.37), sensitization to 2 or more food allergens and/or aeroallergens (OR, 2.44; 95% CI, 1.49-4.05), and African American race (OR, 2.04; 95% CI, 1.19-3.47). The PARS was replicated in the Isle of Wight birth cohort (sensitivity = 0.67, specificity = 0.79), demonstrating that it is a robust, valid, and generalizable asthma predictive tool. CONCLUSIONS: The PARS performed better than the API in children with mild-to-moderate asthma. This is significant because these children are the most common and most difficult to predict and might be the most amenable to prevention strategies.
Authors: Grace K LeMasters; Kimberly Wilson; Linda Levin; Jocelyn Biagini; Patrick Ryan; James E Lockey; Sherry Stanforth; Stephanie Maier; Jun Yang; Jeff Burkle; Manuel Villareal; Gurjit K Khurana Hershey; David I Bernstein Journal: J Pediatr Date: 2006-10 Impact factor: 4.406
Authors: Yulia Y Iossifova; Tiina Reponen; Patrick H Ryan; Linda Levin; David I Bernstein; James E Lockey; Gurjit K Khurana Hershey; Manuel Villareal; Grace LeMasters Journal: Ann Allergy Asthma Immunol Date: 2009-02 Impact factor: 6.347
Authors: Theresa W Guilbert; Wayne J Morgan; Robert S Zeiger; Leonard B Bacharier; Susan J Boehmer; Marzena Krawiec; Gary Larsen; Robert F Lemanske; Andrew Liu; David T Mauger; Chris Sorkness; Stanley J Szefler; Robert C Strunk; Lynn M Taussig; Fernando D Martinez Journal: J Allergy Clin Immunol Date: 2004-12 Impact factor: 10.793
Authors: R J Kurukulaaratchy; M H Fenn; L M Waterhouse; S M Matthews; S T Holgate; S H Arshad Journal: Clin Exp Allergy Date: 2003-05 Impact factor: 5.018
Authors: C S Devulapalli; K C L Carlsen; G Håland; M C Munthe-Kaas; M Pettersen; P Mowinckel; K-H Carlsen Journal: Thorax Date: 2007-07-05 Impact factor: 9.139
Authors: Michael G Sherenian; Jocelyn M Biagini Myers; Lisa J Martin; Gurjit K Khurana Hershey Journal: Expert Rev Clin Immunol Date: 2019-10-24 Impact factor: 4.473
Authors: Jocelyn M Biagini; John W Kroner; Asel Baatyrbek Kyzy; Alexandra Gonzales; Hua He; Mariana Stevens; Brittany Grashel; Daniel Spagna; Samuel Paul; Rahul Patel; Angelo Bucci; Michael G Sherenian; Liza Bronner Murrison; Lisa J Martin; Gurjit K Khurana Hershey Journal: J Allergy Clin Immunol Date: 2021-10-18 Impact factor: 14.290
Authors: Eric Schauberger; Jocelyn M Biagini Myers; Hua He; Lisa J Martin; S Hasan Arshad; Ramesh Kurukulaaratchy; Gurjit K Khurana Hershey Journal: Ann Allergy Asthma Immunol Date: 2020-03-20 Impact factor: 6.347
Authors: Tesfaye B Mersha; Ke Qin; Andrew F Beck; Lili Ding; Bin Huang; Robert S Kahn Journal: J Allergy Clin Immunol Date: 2021-07-01 Impact factor: 10.793
Authors: Ronaldo C Fabiano Filho; Ruth J Geller; Ludmilla Candido Santos; Janice A Espinola; Lacey B Robinson; Kohei Hasegawa; Carlos A Camargo Journal: Front Allergy Date: 2021-10-22